1. Pfizer/BioNTech COVID-19 vaccine is safe for elderly people, says WHO — JNJ plans to have 100 million vaccine doses for the US by spring — Assessing physician practices and expectations in the post-COVID era — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

How CMOs can help reduce your manufacturing risk

Discussion in 'Pharma Contract Manufacturing - General Discussion' started by anonymous, Mar 8, 2012 at 3:57 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    This new white paper is hosted at Pharmaceutical Technology. Contract manufacturing organizations (CMOs) exist in an environment of continuous improvement and evolving quality standards.

    http://www.pharmtech.com/pharmtech/...cturing/ArticleStandard/Article/detail/758711

    By scientifically affirming every decision and by embracing integral approaches to quality, CMOs can reduce regulatory risk and become a leader in developing best practices meeting current Good Manufacturing Practices (cGMPs).